AdjuCor Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Latest Deal Amount
-
$21.5M
- Investors
-
3
AdjuCor General Information
Description
Developer of a heart assist device designed to support the function of the heart in patients with advanced heart failure. The company's device specializes in providing pulsatile support to the heart without blood contact, enabling patients with improved blood flow, faster recovery, and equality of life.
Contact Information
Website
www.adjucor.comCorporate Office
- Neumarkter Street 18
- 81673 Munich
- Germany
Corporate Office
- Neumarkter Street 18
- 81673 Munich
- Germany
AdjuCor Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | $21.5M | Cancelled | Clinical Trials - General | |||
| 3. Accelerator/Incubator | 01-Jun-2022 | Completed | Clinical Trials - General | |||
| 2. Later Stage VC (Series B) | 09-Jun-2021 | $35.3M | $47.5M | Completed | Pre-Clinical Trials | |
| 1. Later Stage VC | 21-Dec-2019 | $12.2M | $12.2M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
AdjuCor Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
AdjuCor Patents
AdjuCor Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4719581-A1 | Cardiac assist device comprising an expandable unit | Pending | 30-May-2023 | ||
| WO-2024245790-A1 | Cardiac assist device comprising an expandable unit | Inactive | 30-May-2023 | ||
| DE-102023114148-A1 | Cardiac assistance device with an expandable unit | Pending | 30-May-2023 | ||
| DE-102022202613-A1 | Adaptable cover for a medical implant | Pending | 16-Mar-2022 | ||
| EP-4245256-A1 | Conformable sheath for a medical implant | Active | 16-Mar-2022 | A61F2/0063 |
AdjuCor Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
AdjuCor Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | |||
| MitrAssist | Corporation | Minority | ||
| Maurizio Capital | Venture Capital | Minority |
AdjuCor FAQs
-
When was AdjuCor founded?
AdjuCor was founded in 2012.
-
Where is AdjuCor headquartered?
AdjuCor is headquartered in Munich, Germany.
-
What is the size of AdjuCor?
AdjuCor has 25 total employees.
-
What industry is AdjuCor in?
AdjuCor’s primary industry is Therapeutic Devices.
-
Is AdjuCor a private or public company?
AdjuCor is a Private company.
-
What is AdjuCor’s current revenue?
The current revenue for AdjuCor is .
-
How much funding has AdjuCor raised over time?
AdjuCor has raised $50.1M.
-
Who are AdjuCor’s investors?
European Innovation Council, MitrAssist, and Maurizio Capital have invested in AdjuCor.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
